View Full Paper

Owner Consent Verified
Policy Brief 4.5

Clinical Trials and Data Quality And Bias among Pharmaceutical Firms — Post-Pandemic Lessons

8
Pages
MLA
Style
~ 8–12 mins
Reading Time
Data Privacy Supply Chain AIOps
Abstract

This policy brief investigates “Clinical Trials and Data Quality And Bias among Pharmaceutical Firms — Post-Pandemic Lessons” using a social network analysis. Through a institutional lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

Clinical Trials and Data Quality And Bias among Pharmaceutical Firms — Post-Pandemic Lessons

ABSTRACT
Clinical Trials and Data Quality And Bias among Pharmaceutical Firms — Post-Pandemic Lessons is unpacked across themes: scalability, governance, usability, and KPIs. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
14 Pages 4.6
FinTech and Data Quality And Bias among Cross-functional Tech Teams — A Comparative Perspective
Cybersecurity Tourism FinTech
View Paper
13 Pages 4.7
Impact Investing and Interoperability among E-commerce Marketplaces — A systematic literature review
Green Finance Tourism Psychology
View Paper
28 Pages 4.5
Data Quality And Bias in UX Research for E-commerce Marketplaces: A time-series forecasting
MLOps Governance Data Privacy
View Paper